Physician profile
Tamara L Watkins
NPI 1922163120
$518.14
in general payments reported to CMS, 2019-2025
7 companies · $250 in 2025
The $250 reported for 2025 was more than what 80% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $54.01 · 2022: $197 · 2023: $16.92 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $136 · Food and Beverage: $114 · Education: $16.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $136.12 |
| Food and Beverage | $113.73 |
| Education | $16.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biolase, INC. | $159.10 | 2022 | |
| Voco America INC. | $136.12 | 2025 | Grandio Seal, Admira Fusion X-Tra, Voco Profluorid Varnish |
| Patterson Companies, INC. | $113.73 | 2025 | |
| Septodont INC. | $54.01 | 2020 | |
| Zimvie INC. | $24.76 | 2022 | |
| Gc America INC. | $16.92 | 2023 | Gc Fuji |
| Colgate Oral Pharmaceuticals, INC. | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Watkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.